Published in BMC Gastroenterol on November 14, 2006
Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol (2008) 2.33
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J Gastroenterol (2010) 0.91
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells. Hepatol Res (2009) 0.85
The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice. Gastroenterol Res Pract (2015) 0.85
Resveratrol and liver: A systematic review. J Res Med Sci (2015) 0.84
Critical review of resveratrol in xenobiotic-induced hepatotoxicity. Food Chem Toxicol (2015) 0.80
Resveratrol, wine, and atherosclerosis. Int J Angiol (2012) 0.77
Resveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats. Balkan Med J (2016) 0.75
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (1997) 10.90
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res (2004) 4.69
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut (1997) 3.25
Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology (1999) 3.24
Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation (2002) 3.10
Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology (1996) 2.91
Cytokines in alcoholic liver disease. Semin Liver Dis (1999) 2.37
Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res (2005) 2.24
Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res (2000) 2.18
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta (1995) 2.06
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res (2002) 1.78
Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology (1998) 1.70
Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer (2001) 1.57
Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol (1991) 1.51
Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol (2000) 1.33
The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol (2000) 1.31
Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med (1984) 1.26
Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology (1994) 1.19
Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol (2002) 1.18
VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr (1986) 1.07
Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroenterol (2000) 1.05
Nutritional supplementation in chronic liver disease: an analytical review. Hepatology (1994) 1.03
Endotoxin and alcoholic liver disease: tolerance and susceptibility. Hepatology (1999) 1.02
Alcohol-induced free radicals in mice: direct toxicants or signaling molecules? Hepatology (2001) 1.01
Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats. Am J Physiol Gastrointest Liver Physiol (2005) 0.99
Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol (2000) 0.95
Herman Award Lecture, 1993: a personal perspective on alcohol, nutrition, and the liver. Am J Clin Nutr (1993) 0.89
Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis. J Antimicrob Chemother (2001) 0.88
Role of alpha(2)-macroglobulin in fever and cytokine responses induced by lipopolysaccharide in mice. Am J Physiol Regul Integr Comp Physiol (2002) 0.88
Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav (2002) 0.86
[Wine at moderate doses: health or disease?]. Med Clin (Barc) (1999) 0.77
Intraoperative monitoring of kinetic total serum calcium levels in primary hyperparathyroidism surgery. J Am Coll Surg (2004) 1.48
[Retroperitoneal Castleman's disease]. Cir Esp (2006) 1.41
[Clinicopathological characteristics and survival outcome of esophageal cancer. Results from a series of 200 patients]. Med Clin (Barc) (2009) 1.39
Late and complete removal of a greenfield filter. J Am Coll Surg (2007) 1.38
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
Patient expectations and health-related quality of life outcomes following total joint replacement. Value Health (2010) 1.16
Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut (2007) 1.04
Variability of indication criteria in knee and hip replacement: an observational study. BMC Musculoskelet Disord (2010) 1.03
MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res (2010) 1.01
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc (2013) 1.00
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat (2012) 0.99
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology (2014) 0.96
Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum (2002) 0.95
Inflammatory mediators of hepatic steatosis. Mediators Inflamm (2010) 0.91
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci (2014) 0.89
Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes. Mult Scler (2011) 0.89
Is hospital discharge administrative data an appropriate source of information for cancer registries purposes? Some insights from four Spanish registries. BMC Health Serv Res (2010) 0.87
A prospective study of the association of patient expectations with changes in health-related quality of life outcomes, following total joint replacement. BMC Musculoskelet Disord (2014) 0.87
Colorectal cancer prognosis twenty years later. World J Gastroenterol (2010) 0.87
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery. BMC Med (2014) 0.85
[Mucinous adenocarcinoma on chronic perianal fistula treated by neoadjuvant chemoradiotherapy and laparoscopy-assisted abdominoperineal amputation]. Cir Esp (2006) 0.84
HLA-DR17 is associated with enthesitis in psoriatic arthritis. Joint Bone Spine (2011) 0.83
Factors involved in stress urinary incontinence 1 year after first delivery. Int Urogynecol J (2009) 0.83
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test. Mayo Clin Proc (2013) 0.83
Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period. World J Gastroenterol (2013) 0.83
HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res Ther (2006) 0.82
[Minimally invasive esophagectomy]. Cir Esp (2006) 0.82
Biochemical determination of lipid content in hepatic steatosis by the Soxtec method. World J Gastroenterol (2010) 0.82
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2. Mov Disord (2013) 0.81
[Plasma levels of folate and vitamin B(12) in patients with chronic liver disease]. Gastroenterol Hepatol (2010) 0.81
Stress urinary incontinence six months after first vaginal delivery. Eur J Obstet Gynecol Reprod Biol (2010) 0.80
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions. Eur J Gastroenterol Hepatol (2014) 0.80
Global self-regulation of the cellular metabolic structure. PLoS One (2010) 0.80
Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis. Joint Bone Spine (2011) 0.79
Colorectal cancer in a second round after a negative faecal immunochemical test. Eur J Gastroenterol Hepatol (2015) 0.78
Factors involved in the persistence of stress urinary incontinence from pregnancy to 2 years post partum. Int J Gynaecol Obstet (2011) 0.78
Effect of liver resection on the progression and growth of rhabdomyosarcoma metastases in a rat model. J Surg Res (2007) 0.78
Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis. Joint Bone Spine (2008) 0.78
Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control (2014) 0.78
Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset. Clin Exp Rheumatol (2012) 0.78
Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis. Clin Dev Immunol (2013) 0.78
[Expression of multiple-drug resistant proteins in lung cancer]. Cir Esp (2006) 0.78
[Treatment of respiratory infection by Pseudomonas aeruginosa in adult patients within a hospital at home service: clinical characteristics and analysis of prognostic factors for relapse]. Enferm Infecc Microbiol Clin (2009) 0.78
Adaptation and validation of the Osteoarthritis Knee and Hip Quality of Life (OAKHQOL) questionnaire for use in patients with osteoarthritis in Spain. Clin Rheumatol (2011) 0.77
Influence of maternal weight on the new onset of stress urinary incontinence in pregnant women. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.77
Changes in iodine nutrition status in schoolchildren from the Basque Country. Endocrinol Nutr (2012) 0.76
Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic colorectal cancer patients. Exp Dermatol (2014) 0.76
[Expression of multidrug resistance (MDR)-associated proteins in solid tumors]. Cir Esp (2006) 0.75
[Epidermoid carcinoma arising in a pilonidal sinus]. Cir Esp (2006) 0.75
Postpartum impairment of pelvic floor muscle function: factors involved and association with prolapse. Int Urogynecol J (2011) 0.75
Diagnosis of Whipple's disease using molecular biology techniques. Rev Esp Enferm Dig (2011) 0.75
[Mucinous cystoadenoma of the pancreas and acute pancreatitis]. Cir Esp (2005) 0.75
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities. Eur J Gastroenterol Hepatol (2015) 0.75
Diagnosis, treatment and follow-up of gastric carcinoid tumors. Analysis of 14 cases. Rev Esp Enferm Dig (2011) 0.75
Could the clinical differences between men and women with psoriatic arthritis be explained in part by genetic factors? Clin Exp Rheumatol (2013) 0.75
[Parathyroid carcinoma arising on transplanted parathyroid tissue after total parathyroidectomy for renal hyperparathyroidism]. Cir Esp (2006) 0.75
["That flesh, pink and perishable": analysis of disease-free survival analysis in breast cancer in Gipuzkoa (Spain) in the presence of competing risks]. Gac Sanit (2009) 0.75
What is the true prevalence of glucagonoma? Indian J Gastroenterol (2007) 0.75
[Acute suppurative thyroiditis]. Cir Esp (2007) 0.75
Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol (2002) 0.75
[Intestinal malrotation after childhood]. Cir Esp (2005) 0.75
Parathyroid carcinoma on transplanted parathyroid tissue after total parathyroidectomy for renal hyperparathyroidism. Am J Clin Oncol (2006) 0.75
Cancer incidence in Gipuzkoa, Spain (1998-2002), and time trends from 1986. Gac Sanit (2008) 0.75